COST-MINIMIZATION ANALYSIS OF DELAFLOXACIN VERSUS STANDARD OF CARE FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) IN JORDAN

被引：0

作者：

Naser, A. ^{[1
]}

Bilbisi, M. ^{[2
]}

Mousa, R. ^{[3
]}

机构：

[1] Isra Univ, Amman, Jordan

[2] Abdali Med Ctr, Amman, Jordan

[3] Univ Jordan, Fac Pharm, Amman, Jordan

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

EE636

引用

页码：S175 / S175

页数：1

共 50 条

[21] Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
Giordano, Philip A.
Pogue, Jason M.
Cammarata, Sue
CLINICAL INFECTIOUS DISEASES, 2019, 68 : S223 - S232
[22] BUDGET IMPACT ANALYSIS OF ORITAVANCIN FOR THE TREATMENT OF MODERATE TO SEVERE ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) FROM A HOSPITAL PERSPECTIVE
Garg, M.
Venugopalan, V.
Premraj, S.
Park, H.
VALUE IN HEALTH, 2018, 21 : S151 - S151
[23] Comparative efficacy of antibiotics for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a systematic review and network meta-analysis
Thom, H.
Thompson, J. C.
Scott, D. A.
Halfpenny, N.
Sulham, K.
Corey, G. R.
CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (08) : 1539 - 1551
[24] COST IMPLICATIONS OF TEDIZOLID USE IN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION (ABSSSI) FOR HOSPITALS AND MANAGED CARE ORGANIZATIONS (MCOS)
Kauf, T.
Xu, P.
Zivkovic, M.
Corvino, F. A.
VALUE IN HEALTH, 2015, 18 (03) : A240 - A240
[25] ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) SIGNS/SYMPTOMS AND PROS: A COMPREHENSIVE LITERATURE REVIEW
Cimms, T. A.
DeBusk, K.
Howard, K.
Siuciak, J. A.
Llorens, L.
Crawley, J.
Halling, K.
Powers, J. H.
VALUE IN HEALTH, 2013, 16 (03) : A32 - A32
[26] Melinta Therapeutics Announces US FDA Approval of Delafloxacin for Acute Bacterial Skin and Skin Structure Infections
Kaye, Donald
CLINICAL INFECTIOUS DISEASES, 2017, 65 (05) : I - II
[27] Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections (vol 80, pg 1247, 2020)
Scott, L. J.
DRUGS, 2020, 80 (14) : 1507 - 1507
[28] Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials
Lan, Shao-Huan
Lai, Chih-Cheng
Lu, Li-Chin
Chang, Shen-Peng
Huang, Hui-Ting
INFECTION AND DRUG RESISTANCE, 2019, 12 : 1415 - 1423
[29] Dalbavancin for the treatment of acute bacterial skin and skin structure infections
Ramdeen, Sheena
Boucher, Helen W.
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (13) : 2073 - 2081
[30] Tedizolid for treatment of acute bacterial skin and skin structure infections
Ye Hui
Lu Xiaoju
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (09) : 1051 - 1060

← 1 2 3 4 5 →